Thursday, January 18, 2018 11:59:12 AM
Regarding the first link (I recommend to read the whole document), page 9 discusses endpoints and page 14 clinical trials in more detail. On that page there is reference to a Data Safety Monitoring Committee. The second link (from the EMA) will explain that further. I hope this helps. Apologies for not being more specific, but I want to avoid at all cost writing something that could be seen as misleading. Best wishes, HB
http://www.esourceresearch.org/eSourceBook/ClinicalTrials/1LearningObjectives/tabid/192/Default.aspx
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003635.pdf
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM